The COVID-19 pandemic has brought about significant changes in Brazil's supplementary health market, leading to new demands and technological solutions.
This has attracted the attention of major industry players, as well as financial institutions and investor groups.
Valuation practices in mergers and acquisitions (M&A) have also adapted, with EBITDA multiples becoming the predominant approach.
Market concentration in the supplementary health market has increased, with larger providers experiencing growth while smaller operators struggle.
This has raised concerns about service quality and availability.
Mergers and acquisitions are being used as a strategic response to enhance competitiveness and operational efficiency.
Large corporations are particularly interested in acquiring health tech assets.
The interplay between concentration, competition, and consumer satisfaction will shape the future of supplementary health services in Brazil.